van Kooten, H A <br/><br/>
Discontinuation of enzyme replacement therapy in adults with Pompe disease: Evaluating the European POmpe Consortium stop criteria.  [electronic resource] 

 -  Neuromuscular disorders : NMD  01 2020 
 - 59-66 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1873-2364 
<br/><br/><label>Standard No.: </label>10.1016/j.nmd.2019.11.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Clinical Decision-Making<br/>Enzyme Replacement Therapy--adverse effects<br/>Female<br/>Glycogen Storage Disease Type II--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Outcome and Process Assessment, Health Care<br/>Practice Guidelines as Topic--standards<br/>Prospective Studies